Hammarplast Medical

OUR PRODUCTS

TransCutan's operations comply with the international quality standard for medical devices ISO 13485

  • T-Port®
  • TauroLock 
  • My Diagnostick


undefined

T-Port® Enteral Access System  
Our own patented solution for long-term access to the gastro intestinal tract
The T-Port is inserted during local anesthesia in the upper abdomen with X-ray assistance. A titanium plate is planted under the skin. This plate is in communication with an outer contact portion protruding through the skin. Inside the T-Port there is a catheter that leads to the small intestine.
The T-Port titanium plate is placed in a pocket just beneath the skin which avoids the creation of an open hole through the skin to the stomach.

Learn more at transcutan.com


undefined

TauroLock Antimicrobial lock solution for vascular access.
TauroLock lock solution for vascular catheters is used to reduce the number of catheter-related infections and to maintain patency. TauroLock lock solution:
⦁ is bactericidal and fungicidal, within 2-4 hours 500 microorganisms are killed
⦁ prevents the formation of biofilm in the catheter
⦁ maintains catheter patency
⦁ is safe for patients and staff
Taurolock can be used in dialysis catheters, central venous catheters, subcutaneous venous  ports and PICC lines. TauroLock can be used for both children and adults. TauroLock is also present with the addition of heparin or urokinase in cases where additional anticoagulant or thrombolytic properties are desirable. For further information about TauroLock please click on the links in the menu on the right. On the manufacturer's website www.taurolock.com there is a possibility to register and get access to many of the studies that are made with TauroLock lock solution.

Learn more at transcutan.com


undefined
Easy diagnosis of cardiac arrhythmia
Every year 25000 care events in Sweden are registered due to acute stroke. Close to 20 % of all strokes precipitated by a clot on the brain are caused by atrial fibrillation. Today all patients with atrial fibrillation in need of preventive treatment are not found. With the help of AF screening these patients can be detected. A health economic evaluation in Sweden made by TLV (dental care and the institute of medicine benefit) shows that costs for AF screening are low compared to health benefits.

Learn more at transcutan.com










Share this page